List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: Lipase
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Condition: Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Interventions: Drug: Placebo;   Drug: Recombinant Microbial Lipase SLV339
2 Active, not recruiting Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: mycophenolate mofetil;   Drug: cyclosporine;   Drug: methylprednisolone
3 Completed A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)
Conditions: Exocrine Pancreatic Insufficiency;   Pancreatitis, Chronic;   Steatorrhea;   Pancreatitis
Interventions: Dietary Supplement: Ensure Plus;   Drug: Pancrelipase in combination with Ensure Plus
4 Not yet recruiting The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study
Condition: Adipose Tissue
Intervention: Other: GIP (glucose dependent insulinotropic peptide) infusion
5 Completed Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
Condition: Obesity
Interventions: Drug: Orlistat;   Other: normo-caloric diet
6 Completed Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
Condition: Replacement Therapy in Preterm Infants
Interventions: Drug: BSSL;   Drug: Placebo
7 Recruiting Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm Infants
Condition: Replacement Therapy in Preterm Infants
Interventions: Drug: BSSL;   Drug: Placebo
8 Completed Randomized Double-Blind Placebo Crossover Study to Evaluate Safety/Efficacy of Two Doses in CP Patients With EPI
Conditions: Chronic Pancreatitis;   Exocrine Pancreatic Insufficiency
Interventions: Drug: Placebo;   Drug: EUR-1008 high dose;   Drug: EUR-1008 low dose
9 Recruiting An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
Condition: Exocrine Pancreatic Insufficiency
Intervention: Drug: VIOKASE 16
10 Completed Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
Conditions: Fatty Liver;   Hepatitis
Interventions: Drug: Orlistat (Xenical);   Behavioral: 1400 kcal diet (30% fat)
11 Completed Genetics, Metabolism and Weight Loss in Older, Obese Veterans
Condition: Obesity
Intervention: Behavioral: Weight Loss
12 Recruiting Use of Ultrase MT12 in Young Cystic Fibrosis Children
Conditions: Cystic Fibrosis;   Pancreatic Insufficiency
Intervention: Drug: Pancrelipase
13 Completed Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency
Conditions: Cystic Fibrosis;   Exocrine Pancreatic Insufficiency
Intervention: Drug: Bucelipase alfa (INN)
14 Completed Efficacy and Safety of ATL-962 in Obese Diabetics
Conditions: Non-Insulin-Dependent Diabetes Mellitus;   Obesity
Interventions: Drug: ATL-962;   Drug: Orlistat
15 Completed Study of Pancreatic Enzyme Product in Pediatric Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
Conditions: Cystic Fibrosis;   Exocrine Pancreatic Insufficiency
Intervention: Drug: EUR-1008, ZENPEP
16 Not yet recruiting Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients
Conditions: Digestive System Diseases;   Pancreatic Disease;   Cystic Fibrosis;   Exocrine Pancreatic Insufficiency
Intervention: Drug: DCI 1020
17 Recruiting Creon After Pancreatic Surgery
Condition: Pancreatic Insufficiency
Interventions: Drug: Creon;   Drug: Placebo
18 Completed Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy
Condition: Gastrectomy
Interventions: Drug: Pancreatin;   Drug: Placebo
19 Active, not recruiting Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
Condition: Pancreatic Insufficiency
Interventions: Drug: Pancreatin;   Drug: Placebo

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services